What did the Joe Rogan episode with Andrew Hubermsan get wrong?
We checked 50 claims from Joe Rogan Experience #2553 - Andrew Hubermsan, aired Sep 14, 2026. 20 claims didn't hold up: 19 distorted, 1 one-sided. By voice match, Joe said 2 of the misses and Andrew Hubermsan 18. The strongest sourced finding: Elite performance in striking martial arts is generally only achievable if training begins at a very young age during the body's maturation process (One-sided). Accurate claims aren't listed on this site, so this is a count of what needed a second look, not a score of anyone's honesty.
0 unresolved findings. These do not count as false claims.
On-air corrections
No separately verified correction is recorded in this briefing. That does not mean none occurred.
Selected claims only. This briefing is assembled from published findings; it is not a complete transcript review or a measure of the speaker’s honesty. Open each check for attribution and sourcing status.
Jamie Meter · Not enough of Joe’s claims rated How the count works ↓
The Jamie Meter
How many times someone at the table should have said “pull that up.”
The meter needs at least five claims that got a verdict either way. This one doesn't have that many.
The meter counts false, distorted and one-sided findings. It is not a percentage. Unverified claims do not count. Selection and extraction affect the total.
We matched each claim to the voice that said it, where one voice clearly owned the moment. The meter counts only Joe’s: 2 of the 20 misses in this episode. Andrew Hubermsan said 18. How we match voices →
The pattern is real in boxing, where most champions did start as children, and the speaker hedged it himself. The framing still leaves out the other side of the evidence. Research on sport specialization finds senior elite athletes often started their main sport relatively late and came from multi-sport backgrounds, and combat sports are generally classified as late specialization sports. Deontay Wilder first walked into a boxing gym at 20 and went on to win an Olympic bronze medal and hold the WBC heavyweight title for five years.
Pinealon is a real synthetic three amino acid peptide from Russian bioregulator research, but its published work is animal and cell studies on protecting brain tissue, and none of it measures sleep. There is no study showing it lengthens REM sleep in people. The amount described also stands out, because REM is about 25% of a night's sleep for a healthy adult, roughly two hours on an eight hour night, so three hours would be well above typical. This is a personal impression rather than a measured effect.
There is a real kernel here. The body clearly gets used to repeated cold, and a small number of studies show that cold habituation can blunt responses to a different stressor such as low oxygen. But the phrase we know for certain goes past what the human data support. A 2025 systematic review and meta-analysis of cold water immersion found no significant effect on stress immediately, at one hour, at 24 hours or at 48 hours, with a single reduction at 12 hours, and the authors describe the evidence base as limited by few trials, small samples and mostly male participants.
The researchers named are real and so is the finding, but it is narrower than described. In the 1994 Cahill and McGaugh study, propranolol removed the memory boost people normally get for an emotionally arousing story while leaving memory for a matched neutral story intact. A meta-analysis of 18 experiments in healthy adults found the same selective pattern, reduced recall of negative or emotionally charged material. Saying a beta blocker blocks learning in general goes past what the evidence shows.
The lethal dose part has real support, since animal safety work has not been able to establish a minimum toxic dose or a lethal dose for BPC-157. But no documented adverse events goes further than the record allows. In its review of BPC-157 for pharmacy compounding, the FDA said the peptide may pose an immunogenicity risk and impurity problems, and that the agency lacks sufficient information to know whether the drug would cause harm when given to humans. Published human use adds up to roughly 30 people across three small studies, so the quiet safety record mostly reflects how little it has been studied.
This is accurate for the tumors that make surgery hardest and wrong as a blanket statement. Diffuse gliomas blend into healthy brain at the edges under normal operating light, which is exactly why surgeons give patients 5-ALA dye that makes tumor cells glow red under blue light. Other common brain tumors do look different: metastases sit inside a glial pseudo-capsule that gives surgeons a visible plane to cut along, and meningiomas are typically well separated from brain tissue. The part about tumors feeling different to the instruments is real, since tumor firmness often differs from normal tissue.
Both issues named are real, but they were not the only reasons and the regulatory record is broader. At the June 2024 advisory committee meeting, members voted 9 to 2 that the data did not show the drug was effective and 10 to 1 that the risks outweighed the benefits, citing the fact that participants could tell whether they got the drug, how long the benefit lasts, the role of the talk therapy itself, and thin data on abuse potential. The FDA's August 2024 letter asked Lykos to run an entire additional Phase 3 trial. The misconduct case happened in a Phase 2 trial in Canada in 2015, and the regulatory concern attached to it was about adverse event reporting and data integrity, not the incident on its own.
The underlying finding is real. In work by Sam Golden, who does run a lab at the University of Washington, roughly 60 to 70 percent of adult male CD-1 mice will press a lever or nose poke for nothing but the chance to attack an intruder mouse, and a subset keep choosing aggression over food and through punishment. The comparison to puzzles that 30 percent of adults worldwide could not solve has no basis. The animals work on standard operant schedules, such as pressing a lever a fixed number of times, not complex puzzles, and there is no measure that puts mouse and human problem solving on the same scale.
Attention does strongly gate adult brain change, and the monkey training studies behind this point are real, but the absolute version does not hold. In human experiments, a few hours of passive touch stimulation, with subjects told not to pay attention to it and free to read or walk around, still raised excitability in the touch area of the cortex and improved their ability to tell two points apart. The researchers describe the protocol as task-free and independent of attention, and report that focusing or distracting attention did not change the size of the improvement. Attention makes adult learning far more efficient, but it is not the only way an adult brain changes.
These drugs do not raise your own GLP-1. Semaglutide is a synthetic stand-in that sits in the blood around 16 to 30 nmol/L at standard weekly doses, against natural GLP-1 levels near 10 to 20 pmol/L, which is where a thousandfold comes from. The problem is that the FDA label states more than 99 percent of semaglutide is bound to a blood protein called albumin, so the free drug that can actually reach the receptor is far lower, closer to tens of times the natural level, and it is a somewhat weaker activator than the body's own GLP-1. Comparing total drug in the blood against free natural hormone makes the gap look bigger than it is.
Large observational studies do link moderate coffee and caffeine to lower dementia risk, often in a U shape with the lowest risk around 2 to 3 cups a day, roughly 300 mg. Those are associations among people who picked their own coffee habits, not proof that caffeine holds off dementia, and some big studies find no coffee effect while very heavy intake tracks with higher risk. The 400 mg figure is not a dementia number at all. It is the FDA's general safety guidance, an amount it describes as not generally associated with negative effects in healthy adults.
The mechanism described is right. The main danger with ibogaine is cardiac, because it stretches out the heart's electrical cycle and can trigger a fatal rhythm, and fatal cases have clustered around existing heart disease and the use of other depressants including opioids. The number is the problem. A forensic review documented 19 deaths closely linked in time to ibogaine, and later tallies run into the dozens, most of them in treatment or detox settings. Two is a floor rather than a picture of what has been reported, and no published work singles out fentanyl specifically as the link.
There is real support for part of this. In a 2025 crossover trial, a 5 minute ice bath at 8 to 12 degrees Celsius did not significantly change cortisol in either the morning or the evening, and long term winter swimming work shows the hormone response fades as people get used to the cold. But a 2025 systematic review of cold water immersion describes the cortisol literature as mixed, with some studies showing increases during cold exposure, so saying every study points one way overstates it. There is also no solid human evidence that cold plunges blunt your cortisol response to unrelated stressors.
The comparison is real but the number has been inflated. It comes from Julianne Holt-Lunstad's 2010 meta-analysis of 148 studies and about 309,000 people, and the benchmark is smoking up to 15 cigarettes a day, which is less than one pack. Holt-Lunstad has publicly pushed back on exactly this exaggeration, noting that people restate her finding as two packs a day when the research does not give an estimate at that level. Multiple packs a day, roughly 40 or more cigarettes, is not what the evidence says.
Cortisol naturally peaks around the sleep to wake transition and drifts down to its low point in the late evening, and that pattern is driven by the body clock in the brain rather than by how large you make the morning peak. Morning light, exercise and caffeine do raise cortisol and help anchor the daily rhythm, which is a reasonable thing to do. What is missing is evidence that deliberately spiking morning cortisol lowers nighttime cortisol. The word ensures claims a guarantee the research does not provide.
The pattern described is real. A quantitative review of alcohol challenge studies found that heavier drinkers and people with a family history of alcohol problems feel more stimulation and less sedation from the same drink, and that difference is partly genetic. What the research does not produce is the 8% figure. These studies report average differences between risk groups rather than a fixed share of the population, so the specific number attached to this real phenomenon is not something the published work supports.
There is a kernel here, because several earlier Phase 2 trials did use two MDMA sessions spaced about a month apart. But the trials that produced the headline PTSD results used three 8-hour MDMA sessions four weeks apart, with three preparatory and nine integration therapy sessions around them, running 18 weeks to the main measurement point, where 67 percent of the MDMA group no longer met the criteria for PTSD. Even the two-session Phase 2 design ran longer than four to six weeks once the preparation and integration sessions are counted.
Part of this holds up. Some studies of whole body cold water immersion find cortisol unchanged or lower, including one that measured a drop about three hours after a 15 minute immersion at 10 degrees Celsius. But flatly saying cold does not raise cortisol is too strong, because the cold pressor test, a hand or foot held in ice water, is a standard laboratory stressor used precisely because it reliably raises cortisol. One study measured cortisol in saliva rising from a median of 0.14 to 0.34 micrograms per deciliter ten minutes after the task. The honest summary is that the answer depends on the protocol and on when you measure, not that cortisol never goes up.
There is evidence behind this, but both the word blocks and the six hour window overstate it. A 2024 systematic review and meta-analysis of eight studies found cold water immersion after lifting was linked to smaller muscle growth, and the authors called it some evidence of a small effect that should be read with caution because study quality was fair to poor. Strength results are more mixed, with one whole-body training trial finding blunted muscle fiber growth but no effect on strength gains. The six hour figure is not a finding from this research: every study in that review applied the cold within 15 minutes of training, so no one has tested a six hour cutoff.
There was a real shift in thinking here, but the date and the age are both off. A standard neuroscience textbook places the old assumption, that major rewiring of the cortex happens mainly in early development, as holding until the late 1970s, and Kaas and Merzenich showed adult monkey cortex reorganizing in the early 1980s, not the early 1990s. No scientific consensus ever set a cutoff at age 25. That figure comes from a separate idea about when the frontal lobes finish maturing, which is not the same as the brain no longer learning.